Provided are a compound of formula (I), an optical isomer thereof, a pharmaceutically acceptable salt thereof, uses of said compound acting as a STING agonist.
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
申请人:Board of Regents, The University of Texas System
公开号:US10633411B2
公开(公告)日:2020-04-28
Cyclic-GMP-AMP synthase (cGAS) and cyclic-GMP-AMP (cGAMP), including 2′3-cGAMP, 2′2-cGAMP, 3′2′-cGAMP and 3′3′-GAMP, are used in pharmaceutical formulations (including vaccine adjuvants), drug screens, therapies, and diagnostics.
PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
申请人:Board of Regents, The University of Texas System
公开号:US20200140477A1
公开(公告)日:2020-05-07
Cyclic-GMP-AMP synthase (cGAS) and cyclic-GMP-AMP (cGAMP), including 2′3-cGAMP, 2′2-cGAMP, 3′2′-cGAMP and 3′3′-GAMP, are used in pharmaceutical formulations (including vaccine adjuvants), drug screens, therapies, and diagnostics.
CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE
申请人:ImmuneSensor Therapeutics, Inc.
公开号:US20220340613A1
公开(公告)日:2022-10-27
Disclosed are cyclic-di-nucleotide cGAMP analogs, methods of synthesizing the compounds, pharmaceutical compositions comprising the compounds thereof, and use of compounds and compositions in medical therapy.